Streetbeat News

Products Services

HUGE

FSD Pharma has begun investigations into ingredients and dietary supplements aimed at promoting weight loss and liver health. This move could signal a strategic pivot or expansion in the company's product offerings, potentially tapping into the lucrative health and wellness market.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:05 pm

ZPTA

Zapata AI (NASDAQ:ZPTA) announced a $1M commercial expansion with Andretti Global, making it Andretti's official AI Partner. This expansion, effective March 28, 2024, aims to enhance Andretti's engineering, operations, and race strategy across multiple racing series through generative AI and technical expertise. The partnership, which began in February 2022, has already seen the development of advanced ML models for race day performance improvements. The new engagement includes building an AI-ready database for Andretti's racing configurations and is expected to contribute to Zapata AI's sequential quarter-over-quarter bookings growth.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:03 pm

BNGO

Bionano Genomics has entered into an OEM partnership with Diagens to commercialize a clinical cytogenetic analysis that combines Optical Genome Mapping (OGM) with Artificial Intelligence (AI). This collaboration aims to enhance the capabilities and applications of cytogenetic testing, potentially leading to more accurate and efficient diagnoses.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 12:03 pm

SYRA

Syra Health has announced the continuation of its partnership with Maricopa County, Arizona, for a third public health training session. This session will focus on cultural humility, emphasizing the importance of understanding and respecting diverse cultural backgrounds in healthcare settings.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 11:55 am

CMND

Clearmind Medicine has entered into an exclusive licensing agreement with Yissum Research Development Company of the Hebrew University of Jerusalem. This agreement is for the development of Generation 3.0 psychedelic compounds aimed at treating mental disorders.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 11:50 am

EPM

PED

PEDEVCO, in partnership with Evolution Petroleum Corporation, has successfully drilled and completed three horizontal San Andres wells in the Chaveroo Field, Permian Basin. These wells, drilled in Q4 2023 and completed by early 2024, have commenced production with promising early results, peaking at 300 to 375 BOEPD per well. The wells are currently exceeding expectations with an average production of over 750 BOEPD in the last 30 days, indicating a positive outlook for future development phases.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 11:39 am

SAGE

Sage Therapeutics announced topline results from its Phase 2 PRECEDENT study of dalzanemdor for treating mild cognitive impairment in Parkinson's Disease, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 11:38 am

MBLY

ROBT

TSM

VXF

Mobileye Global Inc (NASDAQ:MBLY) stock is up amid reports of winning orders for 46 million EyeQ6 Lite chips, anticipated for mid-year vehicle launches. The company, with clients like Volkswagen and Porsche, expects further growth. The EyeQ6 Lite, enhanced by Taiwan Semiconductor Manufacturing Co's (NYSE:TSM) technology, offers advanced assisted driving features. Despite a slight revenue miss in Q4, Mobileye's EPS exceeded expectations. MBLY stock can also be accessed through ETFs like ROBT and VXF.

Portfolio Pulse from Anusuya Lahiri

April 17, 2024 | 11:37 am

ATHE

Alterity Therapeutics presented three posters at the American Academy of Neurology 2024 Annual Meeting, showcasing their work on Parkinson's Disease and Multiple System Atrophy. The presentations included initial biomarker data and baseline characteristics from their ATH434-201 Phase 2 clinical trial.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 11:26 am

MBLY

Mobileye has launched its latest generation system-on-chip and software, EyeQ6 Lite, aimed at accelerating the adoption of Advanced Driver Assistance Systems (ADAS) globally. This new technology is expected to be implemented in 46 million vehicles, enhancing safety and convenience features.

Portfolio Pulse from Benzinga Newsdesk

April 17, 2024 | 11:26 am